{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:03:35Z","timestamp":1777471415602,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,7,3]],"date-time":"2010-07-03T00:00:00Z","timestamp":1278115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00213-010-1923-7","type":"journal-article","created":{"date-parts":[[2010,7,2]],"date-time":"2010-07-02T02:43:04Z","timestamp":1278038584000},"page":"479-491","source":"Crossref","is-referenced-by-count":23,"title":["Contribution of limbic norepinephrine to cannabinoid-induced aversion"],"prefix":"10.1007","volume":"211","author":[{"given":"Ana Franky","family":"Carvalho","sequence":"first","affiliation":[]},{"given":"Arith-Ruth S.","family":"Reyes","sequence":"additional","affiliation":[]},{"given":"Robert C.","family":"Sterling","sequence":"additional","affiliation":[]},{"given":"Ellen","family":"Unterwald","sequence":"additional","affiliation":[]},{"given":"Elisabeth J.","family":"Van Bockstaele","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,7,3]]},"reference":[{"issue":"Suppl 10","key":"1923_CR1","first-page":"16","volume":"61","author":"A Anand","year":"2000","unstructured":"Anand A, Charney DS (2000) Norepinephrine dysfunction in depression. J Clin Psychiatry 61(Suppl 10):16\u201324","journal-title":"J Clin Psychiatry"},{"key":"1923_CR2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0091-3057(01)00578-0","volume":"70","author":"C Arevalo","year":"2001","unstructured":"Arevalo C, de Miguel R, Hernandez-Tristan R (2001) Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters. Pharmacol Biochem Behav 70:123\u2013131","journal-title":"Pharmacol Biochem Behav"},{"key":"1923_CR3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0079-6123(08)63830-3","volume":"88","author":"G Aston-Jones","year":"1991","unstructured":"Aston-Jones G, Chiang C, Alexinsky T (1991) Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog Brain Res 88:501\u2013520","journal-title":"Prog Brain Res"},{"key":"1923_CR4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1749-6632.1999.tb09284.x","volume":"877","author":"G Aston-Jones","year":"1999","unstructured":"Aston-Jones G, Delfs JM, Druhan J, Zhu Y (1999) The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann N Y Acad Sci 877:486\u2013498","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 1","key":"1923_CR5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2008.06.075","volume":"56","author":"WA Carlezon Jr","year":"2009","unstructured":"Carlezon WA Jr, Thomas MJ (2009) Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 56(Suppl 1):122\u2013132. doi: 10.1016\/j.neuropharm.2008.06.075","journal-title":"Neuropharmacology"},{"key":"1923_CR6","author":"AF Carvalho","year":"2010","unstructured":"Carvalho AF, Mackie K, Van Bockstaele EJ (2010) Cannabinoid modulation of limbic forebrain noradrenergic circuitry. Eur J Neurosci. doi: 10.1111\/j.1460-9568.2009.07054.x","journal-title":"Eur J Neurosci"},{"key":"1923_CR7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0376-8716(98)00075-1","volume":"51","author":"SR Childers","year":"1998","unstructured":"Childers SR, Breivogel CS (1998) Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend 51:173\u2013187","journal-title":"Drug Alcohol Depend"},{"key":"1923_CR8","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0006-3223(98)00288-1","volume":"44","author":"M Davis","year":"1998","unstructured":"Davis M (1998) Are different parts of the extended amygdala involved in fear versus anxiety? Biol Psychiatry 44:1239\u20131247","journal-title":"Biol Psychiatry"},{"key":"1923_CR9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1037\/0003-066X.61.8.741","volume":"61","author":"M Davis","year":"2006","unstructured":"Davis M (2006) Neural systems involved in fear and anxiety measured with fear-potentiated startle. Am Psychol 61:741\u2013756. doi: 10.1037\/0003-066X.61.8.741","journal-title":"Am Psychol"},{"key":"1923_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0006-8993(98)00672-6","volume":"806","author":"JM Delfs","year":"1998","unstructured":"Delfs JM, Zhu Y, Druhan JP, Aston-Jones GS (1998) Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res 806:127\u2013140","journal-title":"Brain Res"},{"key":"1923_CR11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/35000212","volume":"403","author":"JM Delfs","year":"2000","unstructured":"Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000) Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403:430\u2013434. doi: 10.1038\/35000212","journal-title":"Nature"},{"key":"1923_CR12","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1098\/rstb.2008.0161","volume":"363","author":"MR Delgado","year":"2008","unstructured":"Delgado MR, Li J, Schiller D, Phelps EA (2008) The role of the striatum in aversive learning and aversive prediction errors. Philos Trans R Soc Lond B Biol Sci 363:3787\u20133800. doi: 10.1098\/rstb.2008.0161","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"1923_CR13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0891-0618(94)90025-6","volume":"7","author":"M Fodor","year":"1994","unstructured":"Fodor M, Pammer C, Gorcs T, Palkovits M (1994) Neuropeptides in the human dorsal vagal complex: an immunohistochemical study. J Chem Neuroanat 7:141\u2013157","journal-title":"J Chem Neuroanat"},{"key":"1923_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainresrev.2004.07.011","volume":"47","author":"MI Forray","year":"2004","unstructured":"Forray MI, Gysling K (2004) Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axis. Brain Res Brain Res Rev 47:145\u2013160. doi: 10.1016\/j.brainresrev.2004.07.011","journal-title":"Brain Res Brain Res Rev"},{"key":"1923_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0361-9230(00)00229-X","volume":"52","author":"MI Forray","year":"2000","unstructured":"Forray MI, Gysling K, Andres ME, Bustos G, Araneda S (2000) Medullary noradrenergic neurons projecting to the bed nucleus of the stria terminalis express mRNA for the NMDA-NR1 receptor. Brain Res Bull 52:163\u2013169","journal-title":"Brain Res Bull"},{"key":"1923_CR16","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1523\/JNEUROSCI.22-03-01146.2002","volume":"22","author":"S Ghozland","year":"2002","unstructured":"Ghozland S, Matthes HW, Simonin F, Filliol D, Kieffer BL, Maldonado R (2002) Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J Neurosci 22:1146\u20131154","journal-title":"J Neurosci"},{"key":"1923_CR17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0893-133X(00)00186-X","volume":"24","author":"KN Gracy","year":"2001","unstructured":"Gracy KN, Dankiewicz LA, Koob GF (2001) Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24:152\u2013160. doi: 10.1016\/S0893-133X(00)00186-X","journal-title":"Neuropsychopharmacology"},{"key":"1923_CR18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1055\/s-2007-979535","volume":"29","author":"GR Heninger","year":"1996","unstructured":"Heninger GR, Delgado PL, Charney DS (1996) The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 29:2\u201311","journal-title":"Pharmacopsychiatry"},{"key":"1923_CR19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","volume":"11","author":"M Herkenham","year":"1991","unstructured":"Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563\u2013583","journal-title":"J Neurosci"},{"key":"1923_CR20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(98)00630-X","volume":"359","author":"T Himmi","year":"1998","unstructured":"Himmi T, Perrin J, El Ouazzani T, Orsini JC (1998) Neuronal responses to cannabinoid receptor ligands in the solitary tract nucleus. Eur J Pharmacol 359:49\u201354","journal-title":"Eur J Pharmacol"},{"key":"1923_CR21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainresbull.2008.10.014","volume":"78","author":"J Jelsing","year":"2009","unstructured":"Jelsing J, Galzin AM, Guillot E, Pruniaux MP, Larsen PJ, Vrang N (2009) Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55, 212\u20132. Brain Res Bull 78:202\u2013210. doi: 10.1016\/j.brainresbull.2008.10.014","journal-title":"Brain Res Bull"},{"key":"1923_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nlm.2007.09.005","volume":"89","author":"EC Kerfoot","year":"2008","unstructured":"Kerfoot EC, Chattillion EA, Williams CL (2008) Functional interactions between the nucleus tractus solitarius (NTS) and nucleus accumbens shell in modulating memory for arousing experiences. Neurobiol Learn Mem 89:47\u201360. doi: 10.1016\/j.nlm.2007.09.005","journal-title":"Neurobiol Learn Mem"},{"key":"1923_CR23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0196-9781(82)90063-8","volume":"3","author":"H Khachaturian","year":"1982","unstructured":"Khachaturian H, Watson SJ, Lewis ME, Coy D, Goldstein A, Akil H (1982) Dynorphin immunocytochemistry in the rat central nervous system. Peptides 3:941\u2013954","journal-title":"Peptides"},{"key":"1923_CR24","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/sj.bjp.0705179","volume":"138","author":"ML Laorden","year":"2003","unstructured":"Laorden ML, Castells MT, Milanes MV (2003) Effects of U-50488H and U-50488H withdrawal on c-fos expression in the rat paraventricular nucleus. Correlation with c-fos in brainstem catecholaminergic neurons. Br J Pharmacol 138:1544\u20131552. doi: 10.1038\/sj.bjp.0705179","journal-title":"Br J Pharmacol"},{"key":"1923_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0166-4328(02)00287-5","volume":"137","author":"L Levita","year":"2002","unstructured":"Levita L, Dalley JW, Robbins TW (2002) Nucleus accumbens dopamine and learned fear revisited: a review and some new findings. Behav Brain Res 137:115\u2013127","journal-title":"Behav Brain Res"},{"key":"1923_CR26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","volume":"168","author":"K Mackie","year":"2005","unstructured":"Mackie K (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. Handb Exp Pharmacol 168:299\u2013325","journal-title":"Handb Exp Pharmacol"},{"issue":"Suppl 1","key":"1923_CR27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2826.2008.01671.x","volume":"20","author":"K Mackie","year":"2008","unstructured":"Mackie K (2008) Cannabinoid receptors: where they are and what they do. J Neuroendocrinol 20(Suppl 1):10\u201314. doi: 10.1111\/j.1365-2826.2008.01671.x","journal-title":"J Neuroendocrinol"},{"key":"1923_CR28","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/S0024-3205(98)00226-4","volume":"62","author":"PE Mallet","year":"1998","unstructured":"Mallet PE, Beninger RJ (1998) Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. Life Sci 62:2431\u20132439","journal-title":"Life Sci"},{"key":"1923_CR29","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(01)00723-3","volume":"412","author":"OJ Manzoni","year":"2001","unstructured":"Manzoni OJ, Bockaert J (2001) Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens. Eur J Pharmacol 412:R3\u2013R5","journal-title":"Eur J Pharmacol"},{"key":"1923_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008877-200402000-00003","volume":"15","author":"EM Marco","year":"2004","unstructured":"Marco EM, Perez-Alvarez L, Borcel E, Rubio M, Guaza C, Ambrosio E, File SE, Viveros MP (2004) Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55, 940 in male rats. Behav Pharmacol 15:21\u201327","journal-title":"Behav Pharmacol"},{"key":"1923_CR31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuroscience.2005.09.005","volume":"137","author":"F Matyas","year":"2006","unstructured":"Matyas F, Yanovsky Y, Mackie K, Kelsch W, Misgeld U, Freund TF (2006) Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience 137:337\u2013361. doi: 10.1016\/j.neuroscience.2005.09.005","journal-title":"Neuroscience"},{"key":"1923_CR32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0091-3057(95)02066-7","volume":"53","author":"IS McGregor","year":"1996","unstructured":"McGregor IS, Issakidis CN, Prior G (1996) Aversive effects of the synthetic cannabinoid CP 55, 940 in rats. Pharmacol Biochem Behav 53:657\u2013664","journal-title":"Pharmacol Biochem Behav"},{"key":"1923_CR33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.nlm.2007.04.008","volume":"88","author":"MA Miranda","year":"2007","unstructured":"Miranda MA, Ferry B, Ferreira G (2007) Basolateral amygdala noradrenergic activity is involved in the acquisition of conditioned odor aversion in the rat. Neurobiol Learn Mem 88:260\u2013263. doi: 10.1016\/j.nlm.2007.04.008","journal-title":"Neurobiol Learn Mem"},{"key":"1923_CR34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47\u201360","journal-title":"J Neurosci Methods"},{"key":"1923_CR35","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(25)13195-9","volume":"253","author":"ES Onaivi","year":"1990","unstructured":"Onaivi ES, Green MR, Martin BR (1990) Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 253:1002\u20131009","journal-title":"J Pharmacol Exp Ther"},{"key":"1923_CR36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2005.03.036","volume":"1046","author":"VC Oropeza","year":"2005","unstructured":"Oropeza VC, Page ME, Van Bockstaele EJ (2005) Systemic administration of WIN 55, 212\u20132 increases norepinephrine release in the rat frontal cortex. Brain Res 1046:45\u201354. doi: 10.1016\/j.brainres.2005.03.036","journal-title":"Brain Res"},{"key":"1923_CR37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2006.09.110","volume":"1127","author":"VC Oropeza","year":"2007","unstructured":"Oropeza VC, Mackie K, Van Bockstaele EJ (2007) Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Res 1127:36\u201344. doi: 10.1016\/j.brainres.2006.09.110","journal-title":"Brain Res"},{"key":"1923_CR38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Batkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389\u2013462. doi: 10.1124\/pr.58.3.2","journal-title":"Pharmacol Rev"},{"key":"1923_CR39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pbb.2006.12.020","volume":"86","author":"ME Page","year":"2007","unstructured":"Page ME, Oropeza VC, Sparks SE, Qian Y, Menko AS, Van Bockstaele EJ (2007) Repeated cannabinoid administration increases indices of noradrenergic activity in rats. Pharmacol Biochem Behav 86:162\u2013168. doi: 10.1016\/j.pbb.2006.12.020","journal-title":"Pharmacol Biochem Behav"},{"key":"1923_CR40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-009-1542-3","volume":"205","author":"P Pandolfo","year":"2009","unstructured":"Pandolfo P, Vendruscolo LF, Sordi R, Takahashi RN (2009) Cannabinoid-induced conditioned place preference in the spontaneously hypertensive rat-an animal model of attention deficit hyperactivity disorder. Psychopharmacology (Berl) 205:319\u2013326. doi: 10.1007\/s00213-009-1542-3","journal-title":"Psychopharmacology (Berl)"},{"key":"1923_CR41","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1997","unstructured":"Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates. Academic, New York"},{"key":"1923_CR42","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873\u2013884. doi: 10.1038\/nrn1247","journal-title":"Nat Rev Neurosci"},{"key":"1923_CR43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1360-0443.1998.9368375.x","volume":"93","author":"D Reilly","year":"1998","unstructured":"Reilly D, Didcott P, Swift W, Hall W (1998) Long-term cannabis use: characteristics of users in an Australian rural area. Addiction 93:837\u2013846","journal-title":"Addiction"},{"key":"1923_CR44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/cne.1097","volume":"432","author":"S Ritter","year":"2001","unstructured":"Ritter S, Bugarith K, Dinh TT (2001) Immunotoxic destruction of distinct catecholamine subgroups produces selective impairment of glucoregulatory responses and neuronal activation. J Comp Neurol 432:197\u2013216","journal-title":"J Comp Neurol"},{"key":"1923_CR45","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/en.2002-221076","volume":"144","author":"S Ritter","year":"2003","unstructured":"Ritter S, Watts AG, Dinh TT, Sanchez-Watts G, Pedrow C (2003) Immunotoxin lesion of hypothalamically projecting norepinephrine and epinephrine neurons differentially affects circadian and stressor-stimulated corticosterone secretion. Endocrinology 144:1357\u20131367","journal-title":"Endocrinology"},{"key":"1923_CR46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1523\/JNEUROSCI.21-01-00109.2001","volume":"21","author":"D Robbe","year":"2001","unstructured":"Robbe D, Alonso G, Duchamp F, Bockaert J, Manzoni OJ (2001) Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J Neurosci 21:109\u2013116","journal-title":"J Neurosci"},{"key":"1923_CR47","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0006-8993(94)90648-3","volume":"638","author":"S Roder","year":"1994","unstructured":"Roder S, Ciriello J (1994) Collateral axonal projections to limbic structures from ventrolateral medullary A1 noradrenergic neurons. Brain Res 638:182\u2013188","journal-title":"Brain Res"},{"key":"1923_CR48","first-page":"200","volume":"58","author":"M Rutkowska","year":"2006","unstructured":"Rutkowska M, Jamontt J, Gliniak H (2006) Effects of cannabinoids on the anxiety-like response in mice. Pharmacol Rep 58:200\u2013206","journal-title":"Pharmacol Rep"},{"key":"1923_CR49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3940(97)13424-3","volume":"223","author":"MC Sanudo-Pena","year":"1997","unstructured":"Sanudo-Pena MC, Tsou K, Delay ER, Hohman AG, Force M, Walker JM (1997) Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci Lett 223:125\u2013128","journal-title":"Neurosci Lett"},{"key":"1923_CR50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2009.11.023","volume":"1312","author":"JL Scavone","year":"2010","unstructured":"Scavone JL, Mackie K, Van Bockstaele EJ (2010) Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors. Brain Res 1312:18\u201331. doi: 10.1016\/j.brainres.2009.11.023","journal-title":"Brain Res"},{"key":"1923_CR51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF02244871","volume":"116","author":"JK Shepherd","year":"1994","unstructured":"Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT (1994) Behavioural and pharmacological characterisation of the elevated \u201czero-maze\u201d as an animal model of anxiety. Psychopharmacology (Berl) 116:56\u201364","journal-title":"Psychopharmacology (Berl)"},{"key":"1923_CR52","doi-asserted-by":"crossref","first-page":"27P","DOI":"10.1016\/j.amjcard.2007.10.011","volume":"100","author":"BA Steinberg","year":"2007","unstructured":"Steinberg BA, Cannon CP (2007) Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potential. Am J Cardiol 100:27P\u201332P. doi: 10.1016\/j.amjcard.2007.10.011","journal-title":"Am J Cardiol"},{"key":"1923_CR53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-8993(94)01453-O","volume":"672","author":"MG Terenzi","year":"1995","unstructured":"Terenzi MG, Ingram CD (1995) A combined immunocytochemical and retrograde tracing study of noradrenergic connections between the caudal medulla and bed nuclei of the stria terminalis. Brain Res 672:289\u2013297","journal-title":"Brain Res"},{"key":"1923_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.903410102","volume":"341","author":"EJ Bockstaele Van","year":"1994","unstructured":"Van Bockstaele EJ, Sesack SR, Pickel VM (1994) Dynorphin-immunoreactive terminals in the rat nucleus accumbens: cellular sites for modulation of target neurons and interactions with catecholamine afferents. J Comp Neurol 341:1\u201315. doi: 10.1002\/cne.903410102","journal-title":"J Comp Neurol"},{"key":"1923_CR55","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1073\/pnas.0610178104","volume":"104","author":"R Ventura","year":"2007","unstructured":"Ventura R, Morrone C, Puglisi-Allegra S (2007) Prefrontal\/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuli. Proc Natl Acad Sci USA 104:5181\u20135186. doi: 10.1073\/pnas.0610178104","journal-title":"Proc Natl Acad Sci USA"},{"key":"1923_CR56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","volume":"81","author":"MP Viveros","year":"2005","unstructured":"Viveros MP, Marco EM, File SE (2005) Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav 81:331\u2013342. doi: 10.1016\/j.pbb.2005.01.029","journal-title":"Pharmacol Biochem Behav"},{"key":"1923_CR57","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2165\/00003495-200060060-00005","volume":"60","author":"EM Williamson","year":"2000","unstructured":"Williamson EM, Evans FJ (2000) Cannabinoids in clinical practice. Drugs 60:1303\u20131314","journal-title":"Drugs"},{"key":"1923_CR58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008877-200509000-00005","volume":"16","author":"JM Witkin","year":"2005","unstructured":"Witkin JM, Tzavara ET, Nomikos GG (2005) A role for cannabinoid CB1 receptors in mood and anxiety disorders. Behav Pharmacol 16:315\u2013331","journal-title":"Behav Pharmacol"},{"key":"1923_CR59","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0006-8993(96)00855-4","volume":"740","author":"CC Wrenn","year":"1996","unstructured":"Wrenn CC, Picklo MJ, Lappi DA, Robertson D, Wiley RG (1996) Central noradrenergic lesioning using anti-DBH-saporin: anatomical findings. Brain Res 740:175\u2013184","journal-title":"Brain Res"},{"key":"1923_CR60","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1523\/JNEUROSCI.21-23-09499.2001","volume":"21","author":"A Zimmer","year":"2001","unstructured":"Zimmer A, Valjent E, Konig M, Zimmer AM, Robledo P, Hahn H, Valverde O, Maldonado R (2001) Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice. J Neurosci 21:9499\u20139505","journal-title":"J Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-010-1923-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-010-1923-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-010-1923-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T13:58:44Z","timestamp":1740232724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-010-1923-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,3]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["1923"],"URL":"https:\/\/doi.org\/10.1007\/s00213-010-1923-7","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,3]]}}}